Immunotherapy – A major breakthrough in cancer treatment

CyPep-O1 lyses cancer cells which potentially induces a potent and long-lasting tumour-specific immune response.

Immunotherapy

CyPep-01

Cytovation’s lead candidate CyPep-01 is a first-in-class peptide with a novel mechanism of action. It has unique pharmacological properties and is stable for months.

About CyPep-01

News